ORXOY (Orexo AB) Other Stockholders Equity : $2.99 Mil (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Orexo AB Other Stockholders Equity?

Orexo AB's Other Stockholders Equity for the quarter that ended in Dec. 2024 was $2.99 Mil.

Orexo AB's quarterly Other Stockholders Equity declined from Jun. 2024 ($2.31 Mil) to Sep. 2024 ($-2.66 Mil) but then increased from Sep. 2024 ($-2.66 Mil) to Dec. 2024 ($2.99 Mil).

Orexo AB's annual Other Stockholders Equity declined from Dec. 2022 ($2.09 Mil) to Dec. 2023 ($1.45 Mil) but then increased from Dec. 2023 ($1.45 Mil) to Dec. 2024 ($2.99 Mil).

Orexo AB Other Stockholders Equity Historical Data

The historical data trend for Orexo AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexo AB Other Stockholders Equity Chart

Orexo AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Stockholders Equity

Get a 7-Day Free Trial

-1.60

-0.04

2.09

1.45

2.99

Orexo AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Stockholders Equity	Get a 7-Day Free Trial															1.45	5.90	2.31	-2.66	2.99

Orexo AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Orexo AB Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Orexo AB's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Orexo AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OTCPK:ORXOY) » Definitions » Other Stockholders Equity

Traded in Other Exchanges

ORX:Sweden 0H19:UK C5G:Germany

Address

Virdings alle 32 A, P.O. Box 303, Uppsala, SWE, 75105

Website

https://www.orexo.com

Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline. The majority is from the USA Pharma segment. Geographically, the majority is derived from the United States. USA Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline includes the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.